South China Morning Post · General
China’s obesity drug makers take on global giants as Novo Nordisk patent expires
· By Julie Zhang
Story summaryPatent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market
Read at South China Morning Post ↗
Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.